Growth Metrics

Q32 Bio (QTTB) Other Gross PP&E Adjustments (2017 - 2026)

Q32 Bio's quarterly Other Gross PP&E Adjustments came in at -$3.4 million in Q1 2026, up 23.77% year-on-year from -$2.8 million in Q1 2025, and up 7.21% quarter-over-quarter from -$3.7 million in Q4 2025.

Q32 Bio has reported Other Gross PP&E Adjustments for 10 years, with the latest figure at -$3.4 million in Q1 2026.

  • For the quarter ending Q1 2026, Other Gross PP&E Adjustments rose 23.77% year-over-year to -$3.4 million; the trailing twelve-month figure through Mar 2026 stood at -$3.4 million (up 23.77% YoY), and the FY2025 full-year result was -$3.7 million, up 6.49% from the prior year.
  • Other Gross PP&E Adjustments for Q1 2026 stood at -$3.4 million, up from -$3.7 million in the prior quarter.
  • The five-year high for Other Gross PP&E Adjustments was -$3.4 million in Q1 2026, with the low at -$21.1 million in Q4 2022.
  • Average Other Gross PP&E Adjustments over 5 years is -$8.5 million, with a median of -$4.5 million recorded in 2025.
  • Year-over-year, Other Gross PP&E Adjustments tumbled 127.08% in 2022 and surged 81.44% in 2024.
  • Tracing QTTB's Other Gross PP&E Adjustments over 5 years: stood at -$21.1 million in 2022, then surged by 44.33% to -$11.8 million in 2023, then surged by 66.36% to -$4.0 million in 2024, then rose by 6.49% to -$3.7 million in 2025, then advanced by 7.21% to -$3.4 million in 2026.
  • The last three Other Gross PP&E Adjustments figures came in at -$3.4 million (Q1 2026), -$3.7 million (Q4 2025), and -$3.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Gross PP&E Adjustments (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -83,048.00
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -60,691.22
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -285.20 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -892,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -1.69 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -189.30 Mn
10 Q32 Bio 162.94 Mn 112.19 Mn - -3.44 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -3.44 Mn
Mar 31, 2026 -3.44 Mn
Dec 31, 2025 -3.70 Mn
Dec 31, 2025 -3.70 Mn
Sep 30, 2025 -3.56 Mn
Sep 30, 2025 -3.56 Mn
Jun 30, 2025 -4.24 Mn
Jun 30, 2025 -4.24 Mn
Mar 31, 2025 -4.51 Mn
Mar 31, 2025 -4.51 Mn
Dec 31, 2024 -3.96 Mn
Dec 31, 2024 -3.96 Mn
Sep 30, 2024 -3.74 Mn
Sep 30, 2024 -3.74 Mn
Jun 30, 2024 -4.35 Mn
Jun 30, 2024 -4.35 Mn
Mar 31, 2024 -4.50 Mn
Mar 31, 2024 -4.50 Mn
Dec 31, 2023 -11.77 Mn
Dec 31, 2023 -11.77 Mn
Sep 30, 2023 -20.15 Mn
Sep 30, 2023 -20.15 Mn
Jun 30, 2023 -13.28 Mn
Jun 30, 2023 -13.28 Mn
Mar 31, 2023 -13.78 Mn
Mar 31, 2023 -13.78 Mn
Dec 31, 2022 -21.14 Mn
Dec 31, 2022 -21.14 Mn
Sep 30, 2022 -13.46 Mn
Sep 30, 2022 -13.46 Mn
Jun 30, 2022 -7.34 Mn
Jun 30, 2022 -7.34 Mn
Mar 31, 2022 -8.45 Mn
Mar 31, 2022 -8.45 Mn
Dec 31, 2021 -14.43 Mn
Dec 31, 2021 -14.43 Mn
Sep 30, 2021 49.69 Mn
Sep 30, 2021 49.69 Mn
Jun 30, 2021 49.15 Mn
Jun 30, 2021 49.15 Mn
Mar 31, 2021 48.47 Mn
Mar 31, 2021 48.47 Mn
Dec 31, 2020 46.11 Mn
Dec 31, 2020 46.11 Mn
Sep 30, 2020 47.39 Mn
Sep 30, 2020 47.39 Mn
Jun 30, 2020 46.29 Mn
Jun 30, 2020 46.29 Mn
Mar 31, 2020 45.63 Mn
Mar 31, 2020 45.63 Mn
Dec 31, 2019 50.24 Mn
Dec 31, 2019 50.24 Mn
Sep 30, 2019 47.54 Mn
Sep 30, 2019 47.54 Mn
Jun 30, 2019 45.69 Mn
Jun 30, 2019 45.69 Mn
Mar 31, 2019 43.88 Mn
Mar 31, 2019 43.88 Mn
Dec 31, 2018 37.30 Mn
Dec 31, 2018 37.30 Mn
Sep 30, 2018 21.88 Mn
Sep 30, 2018 21.88 Mn
Jun 30, 2018 -388,267.00
Jun 30, 2018 -388,267.00
Mar 31, 2018 -1.16 Mn
Mar 31, 2018 -1.16 Mn
Dec 31, 2017 2.93 Mn
Dec 31, 2017 2.93 Mn